Inspiremd Stock Today
| NSPR Stock | USD 2.66 0.06 2.31% |
Performance4 of 100
| Odds Of DistressLess than 9
|
InspireMD is selling at 2.66 as of the 3rd of October 2024; that is 2.31 percent increase since the beginning of the trading day. The stock's lowest day price was 2.56. InspireMD has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for InspireMD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of April 2024 and ending today, the 3rd of October 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of April 2011 | Category Healthcare | Classification Health Care |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company has 25.71 M outstanding shares of which 43.2 K shares are now shorted by private and institutional investors with about 4.35 trading days to cover. More on InspireMD
Moving against InspireMD Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
InspireMD Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Marvin Slosman | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInspireMD can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand InspireMD's financial leverage. It provides some insight into what part of InspireMD's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
InspireMD (NSPR) is traded on NASDAQ Exchange in USA. It is located in 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 and employs 68 people. InspireMD is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 68.12 M. InspireMD conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 25.71 M outstanding shares of which 43.2 K shares are now shorted by private and institutional investors with about 4.35 trading days to cover.
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check InspireMD Probability Of Bankruptcy
Ownership AllocationInspireMD has a total of 25.71 Million outstanding shares. 30% of InspireMD outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check InspireMD Ownership Details
InspireMD Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Mesirow Fin Investmt Mgmt Intl Equity | 2024-06-30 | 30 K | |
| Northern Trust Corp | 2024-06-30 | 24.2 K | |
| Hollencrest Securities, Llc | 2024-06-30 | 20 K | |
| Avestar Capital, Llc | 2024-06-30 | 20 K | |
| Geode Capital Management, Llc | 2024-06-30 | 18.2 K | |
| Renaissance Technologies Corp | 2024-06-30 | 10.8 K | |
| Mckinley Carter Wealth Services Inc | 2024-06-30 | 10 K | |
| Advisornet Financial, Inc | 2024-06-30 | 8.8 K | |
| Royal Bank Of Canada | 2024-06-30 | 1.2 K | |
| Nantahala Capital Management, Llc | 2024-06-30 | 4.1 M | |
| Rosalind Advisors, Inc. | 2024-06-30 | 2.5 M |
InspireMD Historical Income Statement
InspireMD Stock Against Markets
InspireMD Corporate Management
| Shane Gleason | Chief Officer | Profile | |
| Roei Samuri | VP Operations | Profile | |
| DVM MD | Executive Affairs | Profile | |
| Andrea Tommasoli | Chief Officer | Profile | |
| Amir Kohen | Vice Resources | Profile |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.